2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | 0 | 24.867 | 64.729 | 60.886 | 74.157 | 90.638 |
Total Income - EUR | - | - | - | - | 0 | 30.766 | 84.137 | 72.738 | 78.692 | 96.220 |
Total Expenses - EUR | - | - | - | - | 357 | 16.534 | 41.351 | 40.938 | 25.940 | 28.577 |
Gross Profit/Loss - EUR | - | - | - | - | -357 | 14.231 | 42.786 | 31.800 | 52.752 | 67.642 |
Net Profit/Loss - EUR | - | - | - | - | -357 | 13.983 | 42.362 | 31.203 | 52.025 | 66.746 |
Employees | - | - | - | - | 0 | 0 | 4 | 5 | 2 | 2 |
Check the financial reports for the company - Med Narcisa S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | - | - | 0 | 37.803 | 32.058 | 26.629 | 22.575 | 18.383 |
Current Assets | - | - | - | - | 30 | 15.048 | 54.060 | 33.997 | 53.640 | 95.951 |
Inventories | - | - | - | - | 0 | 0 | 0 | 244 | 0 | 0 |
Receivables | - | - | - | - | 0 | 4.506 | 8.614 | 5.329 | 5.566 | 31.407 |
Cash | - | - | - | - | 30 | 10.542 | 45.445 | 28.424 | 48.074 | 64.538 |
Shareholders Funds | - | - | - | - | -314 | 13.675 | 44.897 | 31.501 | 52.324 | 67.044 |
Social Capital | - | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | 344 | 39.176 | 9.467 | 2.595 | 1.812 | 10.863 |
Income in Advance | - | - | - | - | 0 | 0 | 31.753 | 26.529 | 22.078 | 36.428 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Med Narcisa S.r.l.